Clinical Trials Directory

Trials / Sponsors / R-Pharm International, LLC

R-Pharm International, LLC

Industry · 14 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
CompletedPharmacokinetics, Safety and Immunogenicity of RPH-104 at a New Dosage and Different Doses Via Single Subcutan
Healthy
Phase 12024-12-03
WithdrawnEfficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)
Adult-Onset Still's Disease, AOSD
Phase 32023-12-01
RecruitingEfficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases
Lung Diseases, Interstitial
Phase 2 / Phase 32023-08-23
RecruitingPharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis
Phase 22023-03-17
CompletedStudy in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharm
Rheumatoid Arthritis
Phase 12021-11-16
RecruitingSafety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resis
Familial Mediterranean Fever, FMF
Phase 22021-10-05
Active Not RecruitingEfficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Famil
Familial Mediterranean Fever, FMF
Phase 22021-04-29
Active Not RecruitingStudy of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pe
Idiopathic Recurrent Pericarditis
Phase 32020-12-11
CompletedStudy of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in
COVID-19
Phase 2 / Phase 32020-04-23
CompletedStudy to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericardi
Pericarditis
Phase 2 / Phase 32020-02-12
CompletedEfficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 32017-07-04
CompletedEvaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subj
Rheumatoid Arthritis
Phase 32017-01-25
CompletedEvaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adal
Rheumatoid Arthritis
Phase 32016-06-06
CompletedEvaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in
Rheumatoid Arthritis
Phase 32016-05-19